1-11 of 11
J Blade
Close
Sort by
Journal Articles

Pegylated Liposomal Doxorubicin (PLD) in Combination with Bortezomib (B) May Provide Therapeutic Advantage for High-Risk Multiple Myeloma Patients Relapsing within 12 Months of Stem Cell Transplant.

Shaji Kumar, MD, J. Blade, MD, J. San Miguel, MD, R. Hajek, MD, A. Nagler, MD, MSc, P. Sonneveld, MD, PhD, A. Spencer, DM, H.J. Sutherland, MD, PhD, T. Robak, MD, PhD, S.D. Mundle, PhD, S.H. Zhuang, MD, PhD, J.L. Harousseau, MD, R.Z. Orlowski, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2730.
https://doi.org/10.1182/blood.V110.11.2730.2730
Published: 2007
Journal Articles

High-Dose Therapy/Stem Cell Support (HDT), Including Tandem Transplant, for Primary Refractory Multiple Myeloma (MM): Results from the Spanish Myeloma Group (PETHEMA/GEM) in 49 Patients.

L. Rosinol, R. Garcia-Sanz, J. J. Lahuerta, M. Hernandez-Garcia, A. Sureda, J. de la Rubia, J. M. Ribera, B. Hernandez-Ruiz, D. Carreras, I. Navarro, J. C. Garcia-Ruiz, S. Gardella, J. Garcia-Larana, J. Diaz-Mediavilla, J. F. San Miguel, J. Blade
Journal: Blood
Blood (2005) 106 (11): 5472.
https://doi.org/10.1182/blood.V106.11.5472.5472
Published: 2005
Journal Articles

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.

J.F. San Miguel, P. Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 366.
https://doi.org/10.1182/blood.V106.11.366.366
Published: 2005
Journal Articles

Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

Heinz Ludwig, B. Durie, V. Bolejack, A. Hoering, M. Dimopoulos, R. Kyle, R. Fonseca, M. Beksac, J. San Miguel, J. Crowley, J. Blade, M. Boccadoro, H. Avet Loiseau, G. Morgan, K. Shimizu, C. Shustik, P. Sonneveld, P. Tosi, I. Turesson, J. Westin
Journal: Blood
Blood (2005) 106 (11): 3414.
https://doi.org/10.1182/blood.V106.11.3414.3414
Published: 2005
Journal Articles

Hematologic Profiles in the Phase 3 APEX Trial.

Sagar Lonial, P. Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 3474.
https://doi.org/10.1182/blood.V106.11.3474.3474
Published: 2005
Journal Articles

Bortezomib Continues Demonstrates Superior Efficacy Compared with High-Dose Dexamethasone in Relapsed Multiple Myeloma: Updated Results of the APEX Trail.

Paul Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 2547.
https://doi.org/10.1182/blood.V106.11.2547.2547
Published: 2005
Journal Articles

Epidemiology of Multiple Myeloma in Spain: An Analytic Review.

A. Alegre, F. Lara, R. Gabriel, B. Aguado, L.M. Sánchez, S. Damiano, J. San Miguel, J. Blade, J.J. Lahuerta, A. Sureda, J. García-Laraña, J. Díaz Mediavilla, F. de Arriba, J. de la Rubia, F. Prosper, J. Bargay, R. Martínez, C. Martinez-Chamorro, M.T. Hernández, F. Hernández-Navarro, J. Besalduch, M. González-López, J. Petit, C. Solano, L. Hernández-Nieto, J. Baro, R. Parody, R. Cabrera, E. Flores, M.T. Bernal, J.F. Tomás, J.M. Fernández-Rañada
Journal: Blood
Blood (2005) 106 (11): 5089.
https://doi.org/10.1182/blood.V106.11.5089.5089
Published: 2005
Journal Articles

Preliminary Report from an Exploratory Phase II Trial with Plitidepsin (Aplidin®) in Patients with Refractory/Relapsed Multiple Myeloma.

M. V. Mateos, MD, J. Blade, MD, F. Prosper, MD, J. J. Lahuerta, MD, R. Garcia-Sanz, MD, M. Cibeira, MD, L. Rusiñol, MD, F. Escalante, MD, M. Ruiz, MD, P. G. Richardson, MD, J. F. San Miguel, MD
Journal: Blood
Blood (2005) 106 (11): 2569.
https://doi.org/10.1182/blood.V106.11.2569.2569
Published: 2005
Journal Articles

Influence of Age on Survival after a Tandem Hematopoietic Stem Cell Transplantation Procedure in Patients with Multiple Myeloma: Results of the Prospective GEM-2000 Protocol.

A. Sureda, J. Blade, J.J. Lahuerta, J. de la Rubia, R. Martinez, D. Carrera, J. Garcia-Laraña, A. Alegre, M. Hernandez, C. Rivas, J.M. Ribera, M.J. Peñarrubia, L. Palomera, F. Prosper, F. de Arriba, A. Leon, E. Abella, B. Hernandez-Ruiz, F. Casado, J.C. Garcia-Ruiz, J. Besalduch, F.J. Fernandez-Calvo, A. Touchard, J. San Miguel, for the Spanish Group of Multiple Myeloma (MM)
Journal: Blood
Blood (2004) 104 (11): 930.
https://doi.org/10.1182/blood.V104.11.930.930
Published: 2004
Journal Articles

Bortezomib Demonstrates Superior Efficacy to High-Dose Dexamethasone in Relapsed Multiple Myeloma: Final Report of the APEX Study.

Paul Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2004) 104 (11): 1479.
https://doi.org/10.1182/blood.V104.11.1479.1479
Published: 2004
Journal Articles

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

BB Bjorkstrand, P Ljungman, H Svensson, J Hermans, A Alegre, J Apperley, J Blade, K Carlson, M Cavo, A Ferrant, AH Goldstone, A de Laurenzi, I Majolino, R Marcus, HG Prentice, K Remes, D Samson, A Sureda, LF Verdonck, L Volin, G Gahrton
Journal: Blood
Blood (1996) 88 (12): 4711–4718.
https://doi.org/10.1182/blood.V88.12.4711.bloodjournal88124711
Published: 1996